Patent 11492389 was granted and assigned to Ventria Bioscience on November, 2022 by the United States Patent and Trademark Office.
The present invention relates to cell culture media supplements or complete media compositions comprising plant-produced heterologous recombinant human albumin, as well as methods of making the cell culture media, and methods of using the supplemented cell culture media to improve viability, productivity, and growth characteristics of cultured cells.